Search

Home > New FDA Approvals > 107 - Cerapedics initiating study of P-15L bone graft; Solid Biosciences clinical hold on Duchenne drug; President's Cancer Panel report on drug prices.
Podcast: New FDA Approvals
Episode:

107 - Cerapedics initiating study of P-15L bone graft; Solid Biosciences clinical hold on Duchenne drug; President's Cancer Panel report on drug prices.
Category: Science & Medicine
Duration: 00:11:03
Publish Date: 2018-03-15 07:00:00
Description:

March 15, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:00 Cerapedics receives FDA IDE approval to initiate study of P-15L bone graft for transforaminal lumbar interbody fusion surgery

https://www.prnewswire.com/news-releases/cerapedics-receives-fda-ide-approval-to-initiate-study-of-p-15l-bone-graft-for-transforaminal-lumbar-interbody-fusion-surgery-300613602.html 

3:00 Solid Biosciences announces clinical hold on SGT-001 phase I/II clinical trial for Duchenne muscular dystrophy

https://globenewswire.com/news-release/2018/03/14/1422770/0/en/Solid-Biosciences-Announces-Clinical-Hold-On-SGT-001-Phase-I-II-Clinical-Trial-For-Duchenne-Muscular-Dystrophy.html 

5:32 President's Cancer Panel – stresses the need for urgent action on drug prices

https://www.medscape.com/viewarticle/893881 https://prescancerpanel.cancer.gov/report/drugvalue/ 

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0